NCT06765707
Symptom Monitoring Using Patient-Report to Improve Medication Use
Enrolling by Invitation
NAAges 18+InterventionalSupportive careMedical College of WisconsinInvestigator-initiated
~225 participants
Updated 2025-07-24 on ClinicalTrials.gov
What's tested:Pharmacist delivered symptom monitoring and management
At a glance
Recruiting sites
0 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Medication adherence
Measured over From baseline to 12 months
+1 more outcome measured
Conditions
Where it's being run
3 sites across 3 statesIllinois1
Minnesota1
Wisconsin1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Cisgender women assigned female at birth
Age 18 years or older
Stage 1-3 hormone receptor-positive breast cancer
Recommended to continue AET for ≥2 additional years after enrollment
Low adherence defined as prescription fills with a proportion of days covered (PDC) of \<80%, examined over all fills during the 2 years prior to date of eligibility review since the first AET prescription/data of AET start OR unable to calculate adherence
Verbal fluency in English or Spanish
Ability to understand informed consent and the willingness to sign it
Exclusion
Unable to verbalize comprehension of study or impaired decision-making
Known distant metastatic disease
Not receiving breast cancer care or AET prescription from provider at participating site
Evidence that an oncology provider discontinued their AET
Pregnant or trying to get pregnant
Facility-administered medications (i.e., nursing home, home healthcare agency)
What this trial measures
- Medication adherenceFrom baseline to 12 months
Defined as the proportion of total days' pills taken by patients measured by the opening of an electronic pill monitoring cap
- Intervention durability on medication adherenceFrom 12 to 24 months
Assess the durability of AET adherence 1 year post intervention on patients assigned to the intervention phase first. Defined as the proportion of total days' pills taken by patients measured by the opening of an electronic pill monitoring cap